Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
14 January 2026Nanomedicines in the treatment of methicillin-resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus (MRSA) remains a major global threat due to resistance to standard antibiotics and limited therapeutic options. This review outlines why conventional agents—such as β-lactams, glycopeptides, and last-line drugs—are increasingly ineffective and argues for fundamentally new approaches. It highlights five complementary nanotechnology strategies: (1) inorganic and metallic nanoparticles that disrupt biofilms, generate reactive […]
Read more... -
12 January 2026Antimicrobial resistance databases: opportunities and challenges for public health
The article reviews the role of antimicrobial resistance (AMR) databases in modern public health, explaining that these curated repositories of resistance genes and mutations enable the identification of AMR determinants from pathogen genomic data and support prediction of resistance profiles, thereby enhancing surveillance, outbreak response, infection prevention, diagnostic development, and tailored clinical decision-making. It compares […]
Read more... -
12 January 2026EMBL–EBI’s AMR portal: a new gateway in global antimicrobial resistance research
Antimicrobial resistance (AMR) is one of the world’s most serious health threats, with WHO estimating that around one in six common bacterial infections globally no longer responds to standard antibiotics—especially in low- and middle-income countries with limited laboratory capacity. To address critical data gaps in surveillance and diagnostics, European Molecular Biology Laboratory–European Bioinformatics Institute launched […]
Read more...
More news related to Smart innovation
